Nature's Sunshine Products (NATR)
(Delayed Data from NSDQ)
$13.32 USD
+0.40 (3.10%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $13.26 -0.06 (-0.45%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMCompany Summary
Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.
Company Summary
General Information
Nature's Sunshine Products, Inc
2901 WEST BLUEGRASS BOULEVARD SUITE 100
LEHI, UT 84043
Phone: 801-341-7900
Fax: 801-342-4305
Web: http://www.naturessunshine.com
Email: natr@gatewayir.com
Industry | Medical - Drugs |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 9/30/2024 |
Exp Earnings Date | NA |
EPS Information
Current Quarter EPS Consensus Estimate | NA |
Current Year EPS Consensus Estimate | NA |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | NA |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 12.92 |
52 Week High | 21.72 |
52 Week Low | 10.81 |
Beta | 0.87 |
20 Day Moving Average | 29,250.55 |
Target Price Consensus | 19.50 |
4 Week | -5.76 |
12 Week | -20.59 |
YTD | -25.27 |
4 Week | -8.69 |
12 Week | -24.13 |
YTD | -38.71 |
Shares Outstanding (millions) | 18.51 |
Market Capitalization (millions) | 239.12 |
Short Ratio | NA |
Last Split Date | 3/25/1996 |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | NA |
Trailing 12 Months | 16.35 |
PEG Ratio | NA |
vs. Previous Year | -41.67% |
vs. Previous Quarter | -41.67% |
vs. Previous Year | -5.15% |
vs. Previous Quarter | -0.40% |
Price/Book | 1.53 |
Price/Cash Flow | 8.10 |
Price / Sales | 0.54 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 9.79 |
3/31/24 | 10.59 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 6.32 |
3/31/24 | 6.76 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 2.39 |
3/31/24 | 2.33 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 1.41 |
3/31/24 | 1.42 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 3.48 |
3/31/24 | 3.67 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 3.50 |
3/31/24 | 3.69 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 4.90 |
3/31/24 | 5.18 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 8.45 |
3/31/24 | 8.53 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 1.93 |
3/31/24 | 1.90 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 0.00 |
3/31/24 | 0.01 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 0.00 |
3/31/24 | 1.30 |